Notice of Revision to Full-Year Consolidated Earnings Forecast

Summary of Earnings Forecast Revision

Due to increased shipments in the semiconductor business and contributions from new data-center-related areas, sales are expected to exceed the previous forecast. Conversely, in the healthcare business, renegotiation of transaction terms in response to rising raw material prices is underway, and second-half sales are expected to be below the previous forecast. In light of these factors, the full-year sales forecast has been revised upward to 10,323 million yen, operating income to 1,367 million yen, ordinary income to 1,234 million yen, and net income attributable to owners of parent to 1,328 million yen.

Background and Outlook

First-half results exceeded expectations and improvements in gross profit margin also contributed. Based on results for the cumulative second-quarter period and the outlook for the second half, the overall earnings outlook has been reestablished. There is no direct description of foreign exchange impact in this document, so it is Unknown, but the primary factors are segment-specific order trends and negotiations over raw material costs. Key points going forward are securing order terms in the healthcare segment and the delivery capability for new areas.